A new study finds that black people are less likely to keep their viral load down on Atripla -- and that more trouble with side effects may be the reason.
Lipids Respond Well to Switch From Boosted PI to Rilpivirine/Tenofovir/Emtricitabine (Complera), Study Finds
Many people who had high lipid levels while taking common HIV treatment regimens that included a protease inhibitor, such as Prezista or Reyataz, saw remarkable improvements after the switch.
Mental health really matters in HIV. We got a hugely important reminder of that this month in the form of new research regarding suicide and Sustiva (one of the drugs in Atripla).
A single drug dose, taken no more than once a month, to treat HIV: It's no longer the stuff of idle fantasy. But in a world stuffed with excellent once-a-day drugs, will long-acting meds have value?
Vicks VapoRub may be a cheap, effective and safe topical treatment for foot fungus (also known as onychomycosis) among people living with HIV, according to results from a pilot study presented at ID Week 2012.
Onychomycosis is common in both the gen...
What new HIV medications do we have to look forward to over the next few years? How will these newer drugs improve upon the older ones? To shed some light on these questions, Roy Gulick, M.D., recently provided an overview of some of our star HIV dru...
How close are we to an HIV cure? What have we learned from the precious few "functional cure" cases out there, and what other interventions are being developed?
To answer these questions, Joseph Eron, M.D., director of the University of North Caroli...
People with HIV face an increased pneumonia risk even after they've started HIV treatment. However, a recent study suggests that risk isn't affected by how suppressed the immune system was prior to starting treatment.
Because women with HIV have higher rates of cervical cancer than HIV-negative women, cervical cancer screening should be performed annually. However, many women never get screened. Here's how a program in St. Louis reversed the trend.
African-American men who have sex with men (MSM) remain disproportionately affected by the HIV epidemic in the U.S., but the causes of and solutions to this disparity defy easy definition, according to Greg Millett, M.P.H., of the U.S. Centers for Di...